Company Filing History:
1 out of 13 
1 out of 1 
1 out of 10 
Years Active: 2023
Title: Ivan Rivilla De La Cruz: Innovator in Medical Science
Introduction
Ivan Rivilla De La Cruz is a notable inventor based in Bizkaia, Spain, with a significant contribution to the field of medical science. He holds one patent that showcases his commitment to innovative solutions for complex health issues. His work focuses on the treatment of polycystic diseases, emphasizing the importance of research and invention in advancing healthcare.
Latest Patents
Ivan Rivilla De La Cruz's patent is titled "Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases." This groundbreaking invention pertains to compounds derived from ursodeoxycholic acid, formulated to combat various polycystic diseases. These diseases include autosomal dominant polycystic liver disease, autosomal dominant polycystic kidney disease, and autosomal recessive polycystic kidney disease. The methods of obtaining these compounds and their therapeutic applications highlight a significant advancement in the treatment options available for patients suffering from these conditions.
Career Highlights
Throughout his career, Ivan has been associated with several esteemed institutions, including the University of the Basque Country (Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea) and the General Administration of the Autonomous Community of Euskadi (Administración General De La Comunidad Autonoma De Euskadi). His work in these institutions has been pivotal in shaping his research focus and development of innovative medical solutions.
Collaborations
Ivan Rivilla De La Cruz has collaborated with esteemed colleagues such as Jesus Maria Banales Asurmendi and Luis Bujanda Fernandez De Pierola. These partnerships have facilitated the exchange of ideas and resources, further enriching his research endeavors in the realm of polycystic diseases.
Conclusion
Ivan Rivilla De La Cruz exemplifies the spirit of innovation within the medical field. Through his patent on ursodeoxycholic acid derivatives, he has contributed valuable knowledge aimed at improving treatment for polycystic diseases. His collaboration with other experts in the field heralds a promising future for continued advancements in healthcare, showcasing the essential role inventors play in the evolution of medical therapies.